IMMUNOLOGIC FACTORS

Clinical trials for IMMUNOLOGIC FACTORS explained in plain language.

Never miss a new study

Get alerted when new IMMUNOLOGIC FACTORS trials appear

Sign up with your email to follow new studies for IMMUNOLOGIC FACTORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Placental cell therapy for COVID-19 shows early promise but trial halted

Disease control Terminated

This study tested an experimental treatment called CYNK-001, made from natural killer cells derived from placental stem cells, in 7 adults with moderate COVID-19. The goal was to see if these immune cells could safely help fight the virus. The trial was terminated early, so resul…

Matched conditions: IMMUNOLOGIC FACTORS

Phase: PHASE1, PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control

Last updated Jun 12, 2026 12:03 UTC

IMMUNOLOGIC FACTORS

Get alerted when new IMMUNOLOGIC FACTORS trials appear

Placental cell therapy for COVID-19 shows early promise but trial halted